SNYR Synergy CHC Corporation Total Asset Value of Company

SNYR (synergychc.com) - company brandmark

Synergy CHC Corp (SNYR) is a holding company that acquires and scales high-demand beauty and wellness brands, generating profit from consumer loyalty to fast-moving consumer goods. This price chart for total assets, valued at 11.07, reflects the growth of the brand portfolio. However, low barriers to entry in e-commerce compel the company to invest in promotion. Access to retail shelves and compliance with FDA regulations support the stability of the business.

SNYR (Synergy CHC) Company Total Assets history from 10/24/2024 to 10/03/2026

Analytical breakdowns and data insights for company synergychc.com (SNYR)

- stock price and consensus target price:
Price Performance Chart Synergy CHC|SNYR - Price Target Chart
- market capitalization data:
Market Valuation Synergy CHC Corp.|SNYR - Enterprise Value
- issuer book value statistics:
Accounting Value of a Share Synergy CHC|SNYR - Book Capitalization|Market Capitalization to Book Value Ratio synergychc.com|SNYR - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Synergy CHC Corp|SNYR - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Synergy CHC|SNYR - Company Aggregate Debts|Debts to Book Capitalization Synergy CHC Corp.|SNYR - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Synergy CHC|Immediate Liquidity synergychc.com
- net income and valuation multiples indicators:
SNYR - Net Income
Fundamental valuation:Synergy CHC Corp
Manufactured products of Synergy CHC Corp.

This indicator represents the market valuation of total business resources, calculated inversely via return on assets (ROA) to forecast future asset value. By analyzing the total assets chart, an investor can assess the efficiency of brand management within the health and beauty sector, determining how effectively Synergy CHC Corp (SNYR) capital is converted into retail sales growth through online channels.

Key competitors

haleon.com - Aggregate Asset Value|Aggregate Company Assets Kenvue|Verona Pharma PLC - Total Asset Value of Company|Company Total Assets MENS|LGND (Ligand Corp) - Aggregate Asset Value|Company Total Assets AMRX (Amneal Pharmaceuticals)|Company Total Assets perrigo.com PRGO|ALVO - Aggregate Company Assets|Aggregate Asset Value LQDA (Liquidia Corp)|Galapagos Genomics (GLPG) - Aggregate Company Assets|Cumulative Company Assets ANI Pharmaceuticals Corp|MNKD (MannKind Corporation) - Company Total Assets|Company Total Assets amphastar.com|Cumulative Company Assets PCRX (Pacira BioSciences, Inc.)|SPRY (ARS Pharmaceuticals Inc) - Aggregate Asset Value|Aggregate Company Assets Theravance TBPH|Aquestive Corp (AQST) - Company Assets|SCPH: Cumulative Company Assets|Tectonic Therapeutic, Inc. - Aggregate Business Assets|TNXP: Company Total Assets|China SXT Pharmaceuticals, Inc. - Aggregate Asset Value|EPRX (Eupraxia Pharmaceuticals, Inc.) - Company Total Assets|Company Assets BioHarvest Sciences Inc BHST|Aggregate Company Assets eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Aggregate Asset Value|Aggregate Company Assets Entera Bio ENTX|Company Total Asset Base MindWalk Holdings, Inc. (HYFT)|ABVC: Cumulative Company Assets|Company Assets Cumberland Corp|Quantum BioPharma Ltd (QNTM) - Aggregate Company Assets|Total Business Assets FGEN|TELO (Telomir Pharmaceuticals, Inc.) - Company Total Assets|Company Assets Rani Therapeutics Inc RANI|Aggregate Company Assets Rallybio Corporation (RLYB)|LEXX (lexariabioscience.com) - Aggregate Asset Value|Company Total Assets PULM (Pulmatrix, Inc.)|Company Balance Sheet Assets Pheton Holdings Limited|APM: Cumulative Company Assets|Company Assets Lyra Therapeutics Inc.|IBO (Impact BioMedical) - Cumulative Company Assets|TNF Pharmaceuticals, Inc. - Aggregate Asset Value|YCBD (cbdMD Inc.) - Company Total Assets|Cumulative Company Assets painreform.com (PRFX)|Company Total Assets CYTO|LIPO (Lipella Pharmaceuticals Inc) - Aggregate Asset Value|Company Total Assets OPTN (Optinose)|PIRS - Cumulative Company Assets|PROC: Cumulative Company Assets|Aggregate Asset Value PTPI (petrospharma.com)|QLI: Company Total Assets|Cumulative Company Assets Acelyrin Inc.|Aggregate Company Assets TFF Pharma